These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25376731)

  • 1. Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
    Liu B; Zhou W; Chen X; Xu F; Chen Y; Liu J; Zhang Q; Bao S; Chen N; Li M; Zhu R
    Mol Med Rep; 2015 Mar; 11(3):1609-14. PubMed ID: 25376731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
    Lu CJ; He YF; Yuan WZ; Xiang LJ; Zhang J; Liang YR; Duan J; He YH; Li MY
    World J Gastroenterol; 2017 Sep; 23(34):6242-6251. PubMed ID: 28974890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells.
    Liu B; Tan X; Liang J; Wu S; Liu J; Zhang Q; Zhu R
    Sci Rep; 2014 Nov; 4():7041. PubMed ID: 25391369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells.
    Huang X; Lian T; Guan X; Liu B; Hao S; Zhang J; Bao S; Tan X; Zhu R
    Protein Pept Lett; 2017; 24(5):419-424. PubMed ID: 28240161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells.
    Ji FJ; Tian XF; Liu XW; Fu LB; Wu YY; Fang XD; Jin HY
    Genet Mol Res; 2015 Dec; 14(4):15564-71. PubMed ID: 26634523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.
    Hubackova S; Kucerova A; Michlits G; Kyjacova L; Reinis M; Korolov O; Bartek J; Hodny Z
    Oncogene; 2016 Mar; 35(10):1236-49. PubMed ID: 25982278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
    Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
    Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.
    Liu B; Shi Y; Peng W; Zhang Q; Liu J; Chen N; Zhu R
    Mol Med Rep; 2016 Jul; 14(1):159-64. PubMed ID: 27176768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.
    Sancho P; Bertran E; Caja L; Carmona-Cuenca I; Murillo MM; Fabregat I
    Biochim Biophys Acta; 2009 Feb; 1793(2):253-63. PubMed ID: 18848961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
    Zhou DZ; Sun HY; Yue JQ; Peng Y; Chen YM; Zhong ZJ
    Free Radic Res; 2017 May; 51(5):517-528. PubMed ID: 28482716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
    Jiang L; Zhang Q; Ren H; Ma S; Lu C; Liu B; Liu J; Liang J; Li M; Zhu R
    PLoS One; 2015; 10(4):e0124994. PubMed ID: 25915649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.
    Crosas-Molist E; Bertran E; Sancho P; López-Luque J; Fernando J; Sánchez A; Fernández M; Navarro E; Fabregat I
    Free Radic Biol Med; 2014 Apr; 69():338-47. PubMed ID: 24509161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway.
    Zhou MQ; Shao L; Wu J; Peng N; Jin LP; Wei GZ; Cheng W; Deng CJ
    Mol Med Rep; 2017 Dec; 16(6):8983-8988. PubMed ID: 29039483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
    Xie J; Liu J; Chen TM; Lan Q; Zhang QY; Liu B; Dai D; Zhang WD; Hu LP; Zhu RZ
    World J Gastroenterol; 2015 May; 21(18):5473-81. PubMed ID: 25987769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
    Jiang L; Ye WC; Li Z; Yang Y; Dai W; Li M
    BMC Complement Med Ther; 2021 Jul; 21(1):194. PubMed ID: 34229692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
    Huang H; Hu M; Zhao R; Li P; Li M
    Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.
    Wu S; Liu B; Zhang Q; Liu J; Zhou W; Wang C; Li M; Bao S; Zhu R
    PLoS One; 2013; 8(11):e76886. PubMed ID: 24223706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoobtusilactone A-induced apoptosis in human hepatoma Hep G2 cells is mediated via increased NADPH oxidase-derived reactive oxygen species (ROS) production and the mitochondria-associated apoptotic mechanisms.
    Chen CY; Liu TZ; Chen CH; Wu CC; Cheng JT; Yiin SJ; Shih MK; Wu MJ; Chern CL
    Food Chem Toxicol; 2007 Jul; 45(7):1268-76. PubMed ID: 17321026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
    Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.